| Literature DB >> 35184245 |
Claire M Vajdic1, Brigid M Lynch2,3,4, Zohreh Basiri5, Yi Yang5,6, Fiona J Bruinsma5,6, Anna K Nowak7,8, Kerrie L McDonald9, Katharine J Drummond10, Mark A Rosenthal10, Eng-Siew Koh11,12, Rosemary Harrup13, Elizabeth Hovey14,15, David Joseph16, Geza Benke17, Robyn Leonard18, Robert J MacInnis5,6, Roger L Milne5,6,19, Graham G Giles5,6,19.
Abstract
PURPOSE: High-grade disease accounts for ~ 70% of all glioma, and has a high mortality rate. Few modifiable exposures are known to be related to glioma risk or mortality.Entities:
Keywords: Case–control study; Glioma; Physical activity; Survival
Mesh:
Year: 2022 PMID: 35184245 PMCID: PMC9010385 DOI: 10.1007/s10552-022-01559-w
Source DB: PubMed Journal: Cancer Causes Control ISSN: 0957-5243 Impact factor: 2.506
Fig. 1Flow of participants through the study
Characteristics of cases (n = 495) and controls (n = 371) in the glioma family case–control study
| Participant characteristics | Cases | Controls |
|---|---|---|
| Participants (n) | 495 | 371 |
| Days between diagnosis and consent, mean (SD) | 92.5 (171.3) | – |
| Age (years), mean (SD) | 54.2 (14.5) | 54.3 (13.5) |
| Men, | 312 (63.0) | 140 (37.7) |
| BMI (kg/m2), mean (SD) | 27.7 (5.7) | 27.0 (5.1) |
| Caucasians, | 447 (91.0) | 351 (94.9) |
| College education, | 161 (32.7) | 142 (38.3) |
| High income, | 121 (28.7) | 119 (37.7) |
| Current smokers, | 47 (9.7) | 23 (6.3) |
| Alcohol (grams/wk), median (IQR) | 49 (128) | 54 (139) |
| Physical activity in past 10 years (MET-h/wk), mean (SD) | 32.2 (18.2) | 34.0 (17.0) |
| < 24 MET-h/wk (ref) physical activity in last 10 years, | 152 (38.4) | 94 (29.9) |
| 24–< 47 MET-h/wk physical activity in past 10 years, | 117 (29.6) | 111 (35.4) |
| ≥ 47 MET-h/wk physical activity in past 10 years, | 127 (32.1) | 109 (34.7) |
| Lifetime physical activity, (MET-h/wk), mean (SD) | 34.4 (15.2) | 36.0 (14.7) |
| Screen time in one year before diagnosis (h/wk), mean (SD) | 20.9 (6.4) | 21.4 (6.0) |
All statistics in the table are based on the complete case data prior to multiple imputation
Odds ratios and 95% confidence intervals for glioma diagnosis in relation to physical activity at different ages and lifetime physical activity in Australia (2012–2014)
| Cases in original dataset* | Cases after multiple imputation** | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||||
| Previous 10 years (per 10 MET-h/wk)a | 396 | 494 | 0.95 (0.87–1.04) | 0.269 | 0.95 (0.87–1.04) | 0.284 |
| < 24 MET-h/wk (ref)a | 152 | 191 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 117 | 150 | 0.74 (0.52–1.06) | 0.102 | 0.74 (0.51–1.07) | 0.107 |
| ≥ 47 MET-h/wk | 127 | 153 | 0.78 (0.53–1.14) | 0.196 | 0.78 (0.53–1.14) | 0.203 |
| 30–39 years of age (per 10 MET-h/wk)b | 381 | 494 | 0.94 (0.86–1.03) | 0.187 | 0.94 (0.86–1.03) | 0.190 |
| < 24 MET-h/wk (ref)b | 123 | 163 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 143 | 183 | 1.05 (0.71–1.54) | 0.818 | 1.04 (0.71–1.55) | 0.826 |
| ≥ 47 MET-h/wk | 115 | 148 | 0.71 (0.48–1.05) | 0.086 | 0.71 (0.48–1.04) | 0.082 |
| 19–29 years of age (per 10 MET-h/wk)b | 415 | 494 | 0.92 (0.84–1.01) | 0.082 | 0.92 (0.84–1.01) | 0.069 |
| < 24 MET-h/wk (ref)b | 108 | 132 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 166 | 197 | 1.05 (0.71–1.56) | 0.808 | 1.04 (0.70–1.55) | 0.846 |
| ≥ 47 MET-h/wk | 141 | 165 | 0.73 (0.49–1.08) | 0.116 | 0.72 (0.48–1.07) | 0.102 |
| 15–18 years of age (per 10 MET-h/wk)c | 408 | 494 | 0.88 (0.80–0.96) | 0.003 | 0.88 (0.81–0.96) | 0.006 |
| < 24 MET-h/wk (ref)c | 133 | 164 | 1.00 | 1.00 | ||
| 24–< 47 METh/wk | 125 | 155 | 0.74 (0.51–1.06) | 0.101 | 0.79 (0.54–1.16) | 0.227 |
| ≥ 47 MET-h/wk | 150 | 175 | 0.57 (0.39–0.83) | 0.003 | 0.59 (0.40–0.87) | 0.007 |
| Lifetime activity (per 10 MET-h/wk)a | 334 | 494 | 0.89 (0.80–0.99) | 0.031 | 0.89 (0.80–0.99) | 0.033 |
| < 24 MET-h/wk (ref)a | 93 | 140 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 151 | 237 | 0.82 (0.55–1.21) | 0.321 | 0.82 (0.55–1.22) | 0.322 |
| ≥ 47 MET-h/wk | 90 | 117 | 0.58 (0.38–0.89) | 0.012 | 0.58 (0.38–0.89) | 0.013 |
*Number of cases in the unimputed dataset
**Averaged number of cases in each imputed dataset included in the analysis
aModel 1 adjusted for age, sex, ethnicity, income, education, screen time, smoking, alcohol; model 2 additionally adjusted for BMI
bModel 1 adjusted for sex, ethnicity, income, education; model 2 additionally adjusted for age, screen time, smoking and alcohol
cModel 1 adjusted for sex, ethnicity; model 2 additionally adjusted for age, income, education, screen time, smoking and alcohol
dModel 1 adjusted for sex, ethnicity; model 2 additionally adjusted for age, alcohol, smoking, income, education, screen time
Hazard ratios and 95% confidence intervals for all-cause mortality following glioma diagnosis in relation to physical activity at different ages and lifetime physical activity
| No. deaths/person months | Model 1 | Model 2 | |||
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | ||||
| Past 10 years (10 MET-h/wk)a | 332/14,998 | 0.97 (0.91–1.04) | 0.335 | 0.99 (0.92–1.06) | 0.725 |
| < 24 MET-h/wk (ref)a | 131/5,786 | 1.00 | 1.00 | ||
| 24—< 47 MET-h/wk | 102/4,369 | 0.91 (0.68–1.23) | 0.542 | 0.96 (0.71–1.30) | 0.776 |
| ≥ 47 MET-h/wk | 99/4,844 | 0.89 (0.67–1.18) | 0.420 | 0.95 (0.71–1.27) | 0.739 |
| 30–39 years of ageb | 332/1,4998 | 1.00 (0.93–1.07) | 0.958 | 0.96 (0.90–1.03) | 0.284 |
| < 24 MET-h/wk (ref)b | 116/4,834 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 119/5,693 | 0.85 (0.64–1.13) | 0.269 | 0.75 (0.56–1.01) | 0.060 |
| ≥ 47 MET-h/wk | 97/4,472 | 0.96 (0.71–1.29) | 0.776 | 0.83 (0.61–1.13) | 0.244 |
| 19–29 years of agec | 332/14,998 | 0.99 (0.93–1.06) | 0.747 | 0.99 (0.92–1.06) | 0.727 |
| < 24 MET-h/wk (ref)c | 88/4,129 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 140/5,738 | 1.18 (0.89–1.56) | 0.264 | 1.20 (0.90–1.60) | 0.211 |
| ≥ 47 MET-h/wk | 104/5,131 | 1.02 (0.75–1.39) | 0.896 | 1.03 (0.75–1.42) | 0.851 |
| 15–18 years of aged | 332/14,998 | 0.98 (0.92–1.05) | 0.599 | 1.01 (0.95–1.08) | 0.715 |
| < 24 MET-h/wk (ref)d | 117/5,059 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 99/4,744 | 0.85 (0.64–1.13) | 0.256 | 0.92 (0.68–1.24) | 0.583 |
| ≥ 47 MET-h/wk | 116/5,195 | 0.94 (0.71–1.23) | 0.634 | 1.09 (0.81–1.47) | 1.578 |
| Lifetime activitya | 332/14,998 | 0.98 (0.90–1.06) | 0.590 | 0.99 (0.92–1.08) | 0.865 |
| < 24 MET-h/wk (ref)a | 98/4,398 | 1.00 | 1.00 | ||
| 24–< 47 MET-h/wk | 162/6,804 | 1.02 (0.71–1.37) | 0.870 | 1.07 (0.80–1.43) | 0.659 |
| ≥ 47 MET-h/wk | 72/3,796 | 0.91 (0.64–1.29) | 0.606 | 0.98 (0.68–1.39) | 0.893 |
*Number of deaths/person months is the average across 25 multiple imputed datasets
aModel 1 adjusted for age, sex, ethnicity, income, education, alcohol, smoking, personal cancer history (excluding non-melanoma skin cancer) and screen time; model 2 additionally adjusted for BMI
bModel 1 adjusted for sex, ethnicity, income, education and personal cancer history (excluding non-melanoma skin cancer); model 2 additionally adjusted for age, alcohol, smoking and screen
cModel 1 adjusted for sex, ethnicity, income, education; model 2 additionally adjusted for age, alcohol, smoking and screen time